BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 17296885)

  • 1. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study.
    van Vlijmen EF; Brouwer JL; Veeger NJ; Eskes TK; de Graeff PA; van der Meer J
    Arch Intern Med; 2007 Feb; 167(3):282-9. PubMed ID: 17296885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High risk of pregnancy-related venous thromboembolism in women with multiple thrombophilic defects.
    Folkeringa N; Brouwer JL; Korteweg FJ; Veeger NJ; Erwich JJ; van der Meer J
    Br J Haematol; 2007 Jul; 138(1):110-6. PubMed ID: 17555454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users.
    Samuelsson E; Hägg S
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):674-81. PubMed ID: 15225194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
    Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
    Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
    Mills A; Wilkinson C; Fotherby K
    Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study.
    Mahmoodi BK; Brouwer JL; Veeger NJ; van der Meer J
    Circulation; 2008 Oct; 118(16):1659-67. PubMed ID: 18824642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
    Folkeringa N; Coppens M; Veeger NJ; Bom VJ; Middeldorp S; Hamulyak K; Prins MH; Büller HR; van der Meer J
    Thromb Haemost; 2008 Jul; 100(1):38-44. PubMed ID: 18612536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of family history in identifying women with thrombophilia and higher risk of venous thromboembolism during oral contraception.
    Cosmi B; Legnani C; Bernardi F; Coccheri S; Palareti G
    Arch Intern Med; 2003 May; 163(9):1105-9. PubMed ID: 12742811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.
    van Vlijmen EF; Wiewel-Verschueren S; Monster TB; Meijer K
    J Thromb Haemost; 2016 Jul; 14(7):1393-403. PubMed ID: 27121914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene.
    Santamaría A; Mateo J; Oliver A; Menéndez B; Souto JC; Borrell M; Soria JM; Tirado I; Fontcuberta J
    Haematologica; 2001 Sep; 86(9):965-71. PubMed ID: 11532625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of venous thromboembolism in families with inherited thrombophilia.
    Simioni P; Sanson BJ; Prandoni P; Tormene D; Friederich PW; Girolami B; Gavasso S; Huisman MV; Büller HR; Wouter ten Cate J; Girolami A; Prins MH
    Thromb Haemost; 1999 Feb; 81(2):198-202. PubMed ID: 10063991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis of venous thromboembolism: evidence for multiple interrelated causes.
    Brouwer JL; Veeger NJ; Kluin-Nelemans HC; van der Meer J
    Ann Intern Med; 2006 Dec; 145(11):807-15. PubMed ID: 17146065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N; Smith KP
    Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited thrombophilia and venous thromboembolism.
    Simioni P; Tormene D; Spiezia L; Tognin G; Rossetto V; Radu C; Prandoni P
    Semin Thromb Hemost; 2006 Oct; 32(7):700-8. PubMed ID: 17024597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal loss in women with hereditary thrombophilic defects and concomitance of other thrombophilic defects: a retrospective family study.
    Korteweg FJ; Folkeringa N; Brouwer JL; Erwich JJ; Holm JP; van der Meer J; Veeger NJ
    BJOG; 2012 Mar; 119(4):422-30. PubMed ID: 22324918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
    Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
    Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is plasminogen deficiency a thrombotic risk factor? A study on 23 thrombophilic patients and their family members.
    Demarmels Biasiutti F; Sulzer I; Stucki B; Wuillemin WA; Furlan M; Lämmle B
    Thromb Haemost; 1998 Jul; 80(1):167-70. PubMed ID: 9684804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects.
    Lijfering WM; Coppens M; van de Poel MH; Middeldorp S; Hamulyák K; Bank I; Veeger NJ; Prins MH; Büller HR; van der Meer J
    Thromb Haemost; 2007 Aug; 98(2):457-63. PubMed ID: 17721631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.